Recalls & Warnings August 01, 2013 Maker of Algae Products Warned For Drug Claims, Manufacturing Violations On March 8, 2013, the FDA issued a warning letter to Algaen Corporation following a facility inspection and website review which found statements made about the company's AlgaBerry products to be drug claims
The only legal pathway for a compounding pharmacy to prepare any of them is the 503A Bulk Drug Substances List, and thats exactly whats being voted on July 23 and 24
Mold Toxicity and Lyme Disease Mold illness causes many of the same symptoms as Lyme disease
Targets Stubborn Visceral Fat Stacks including Tesamorelin and Ipamorelin are clinically designed to target stubborn visceral fat and abdominal fat directly, while actively preserving lean muscle mass, tracked through DEXA body composition scans
Glutaredoxin 2 knockout increases sensitivity to oxidative stress in mouse lens epithelial cells
We ship it fast (within 72 hours), sell it at competitive prices, and provide COA reports